Aminotetrahydropteridines and processes for manufacture thereof
EP1598354A1
Compounds containing a N-heteroaryl moiety linked to fused ring moieties for the inhibition of NAD(P)H oxidases and platelet activation
CA2552195A1
4-amino-7,8-dihydropteridines, pharmaceutical compositions containing them and their use for the treatment of diseases which are caused by an increased nitric oxide level
WO2005037286A1
Use of pteridine derivatives for the treatment of increased intracranial pressure and secondary ischemia
WO2004017955A1
L-arginine containing pharmaceutical composition
EP1530463A1
L-arginine containing pharmaceutical composition
AU6395601A
Test system for determining the activity of cyclo-nucleotide-dependent protein kinases and vasp phosphatases
US6844343B1
N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent
EP1388543A2
Antibodies against phosphorylated VASP (vasodilator-stimulated phosphoprotein), hybridoma cells for their preparation, and their use
HU0204484A3
Ntibodies against phosphorylated vasp (vasodilator-stimulated phosphoprotein), hybridoma cells for their preparation, and their use
HU0004099A2
Antibodies against phosphorylated vasp (vasodilator-stimulated phosphoprotein), hybridoma cells for preparation thereof and use thereof
DE19837015A1
Isolated and purified human soluble guanylyl cyclase alpha1 / beta1 (hsGCalpha1 / beta1)
